Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agents

Document Details

Document Type
Pub Defense Publication
Publication Date
Dec 01, 2018
Source ID
10.1186/s40360-018-0270-x

Entities

People

  • Catherine M. Sherwin
  • Daniel Kalman
  • Erin Touchette
  • Gopi Patel
  • Hari Krishna Ananthula
  • Inger K. Damon
  • Johanna S. Salzer
  • Larry Sallans
  • Milton H. Werner
  • Nadia Gallardo-romero
  • Pankaj B Desai
  • R. Mark Buller
  • Scott Parker
  • Tessa Moir-savitz
  • Victoria Olson

Organizations

  • Defense Threat Reduction Agency